CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in DYN — Dyne Therapeutics, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in DYN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$26,700,928
+$5,699,318 QoQ
Shares Held
1,202,203
+3.8% QoQ
Ownership
0.644%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 245 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DYN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. DYN ranks #55 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in DYN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,700,928 | 1,202,203 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $21,001,610 | 1,158,390 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $22,519,917 | 1,151,325 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $12,741,004 | 1,007,194 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $7,093,075 | 745,071 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $6,842,210 | 654,131 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $15,725,169 | 667,452 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $23,299,579 | 648,652 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $21,211,477 | 601,062 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $13,102,609 | 461,522 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $4,409,854 | 331,568 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $2,915,324 | 325,371 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $3,207,611 | 285,121 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $2,621,767 | 227,584 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,644,165 | 228,142 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,824,911 | 222,434 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,230,781 | 179,153 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,855,478 | 192,477 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,241,966 | 188,559 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,991,131 | 184,183 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $3,190,211 | 151,626 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,902,300 | 122,492 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,727,796 | 82,276 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||